• Home
  • Conference Program

Conference Program





Sunday, April 2nd

7:45 - 8:15 AM
CONTINENTAL BREAKFAST
Salon 7
8:15 - 10:25 AM
RED LIGHT, GREEN LIGHT: STARTING & STOPPING ANTICOAGULATION
Chair/Organizer: Allison Burnett, Steve Deitelzweig
Salon 8

8:15
Understanding DOAC Reversal
Deborah Siegal. University of Ottawa/Ottawa Hospital Research Institute

8:43
Effective Utilization of Periprocedural Anticoagulation
Bishoy Ragheb. VA Eastern Colorado Health Care System

9:09
Speciality Perspective: Neurosurgeon
Matthew Lawson. Tallahassee Neurological Clinic / Tallahassee Memorial Healthcare / FSU

9:37
Speciality Perspective: Gastroenterologist
Jacob Kurlander. University of Michigan

10:04
Post-Case
.

10:04
Q&A
.

10:24
Pre-Case (The Heart of it All)
.
10:25 - 10:45 AM
BREAK
Salon 7
10:45 - 12:30 PM
THE HEART OF IT ALL
Chair/Organizer: Bill Dager, Diane Wirth
Salon 8

10:45
LAAO Devices Overview: What, When, Who, and How
Lisa Baumann Kreuziger. Versiti

11:06
Tracking the Heart: AF Detection, Loop Recorders, & Event Monitors
Cara Pellegrini. San Francisco VA / UCSF

11:32
An Overview of LV Thrombus
Geoffrey Barnes. University of Michigan

11:56
Post-Case
.

11:56
Q&A
.

11:56
Pre-Case (Diagnostic & Prognostic Dilemmas)
.
12:45 - 1:45 PM
ANTICOAGULATION REVERSAL: REAL-WORLD DATA MATTERS, TOO (SPONSORED BY ASTRAZENECA PHARMACEUTICALS)
Salon 1-4

Introduction and assessment of real-world data (RWD) is critically important for FXa inhibitor-related bleeds in treatment-emergent situations, particularly since this crucial information has been limited to date within a complex clinical landscape. Join experts to explore how reversal agents can manage life-threatening bleeds in the presence of anticoagulation and learn how the latest published RWD guide reversal and repletion strategies in anticoagulated patients.

In support of improving patient care, this activity has been planned and implemented by Global Learning Collaborative (GLC) and TotalCME, Inc. GLC is jointly accredited by the American Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE) and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
This activity was planned by and for the healthcare team, and learners will receive 1.0 Interprofessional Continuing Education (IPCE) credits for learning and change.

Please register to attend the session here: https://www.mededonthego.com/ACRWD
Note: Registration is not required to attend, but is highly recommended. Priority to attend will be given to those that pre-register for the session.



2:00 - 4:05 PM
DIAGNOSTIC & PROGNOSTIC DILEMMAS
Chair/Organizer: Scott Kaatz
Salon 8

2:00
D-dimer, DOAC levels and other laboratory Dilemmas
Rita Selby. Associate Professor, Laboratory Medicine and Medicine, University of Toronto

2:35
Diagnosing and Prognostic Models for VTE
Adam Cuker. University of Pennsylvania

2:49
Thrombophilia Testing and Management
Stephan Moll. University of North Carolina School of Medicine

3:16
Addressing Anticoagulation Failure
Anita Rajasekhar. University of Florida

3:43
Post Case
.

3:45
Q&A
.
4:05 - 4:25 PM
BREAK
Salon 7
4:25 - 5:45 PM
ASKED & ANSWERED RAPID FIRE
Chair/Organizer: Arthur Allen, Tracy Minichiello
Salon 8

Topics:
  • DOACs in obesity/bariatric surgery
  • DOACs in patients with bioprosthetic valves
  • DOACs in ESRD/Dialysis
  • DOACs in patients with liver disease
  • DOACS for secondary VTE prophylaxis to reduce or not to reduce the dose



4:25
Panelists
Mark Crowther, Andrea Van Beek, Scott Kaatz, Anita Rajasekhar, Stephan Moll, Allison Burnett.